ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
-0,01%
Bitcoin
67.610,52
0,19%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Elutia Inc (ELUT)

  7. Elutia Inc (ELUT) News

ELUT

Elutia (ELUT)

Elutia Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ELUT
DatumZeitQuelleÜberschriftSymbolFirma
13/05/202423h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
13/05/202414h00GlobeNewswire Inc.Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024NASDAQ:ELUTElutia Inc
09/05/202423h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
09/05/202422h05GlobeNewswire Inc.Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA ClearanceNASDAQ:ELUTElutia Inc
02/05/202422h05GlobeNewswire Inc.Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024NASDAQ:ELUTElutia Inc
24/04/202422h05GlobeNewswire Inc.Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1NASDAQ:ELUTElutia Inc
11/03/202414h15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ELUTElutia Inc
07/03/202422h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
07/03/202422h05GlobeNewswire Inc.Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024NASDAQ:ELUTElutia Inc
22/02/202422h05GlobeNewswire Inc.Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024NASDAQ:ELUTElutia Inc
14/02/202422h40Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ELUTElutia Inc
02/02/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
25/01/202422h56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ELUTElutia Inc
12/01/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
10/01/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
10/01/202422h05GlobeNewswire Inc.Elutia Regains Compliance with Nasdaq Listing RequirementsNASDAQ:ELUTElutia Inc
09/01/202422h17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ELUTElutia Inc
08/01/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
27/12/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
18/12/202314h00GlobeNewswire Inc.Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA ClearanceNASDAQ:ELUTElutia Inc
08/12/202322h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
05/12/202322h54Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ELUTElutia Inc
05/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ELUTElutia Inc
20/11/202322h53Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ELUTElutia Inc
20/11/202322h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
15/11/202323h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
13/11/202322h05GlobeNewswire Inc.Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial ResultsNASDAQ:ELUTElutia Inc
09/11/202315h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
09/11/202314h30GlobeNewswire Inc.Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 MillionNASDAQ:ELUTElutia Inc
07/11/202322h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
 Showing the most relevant articles for your search:NASDAQ:ELUT

Kürzlich von Ihnen besucht

AQSE
EUP3.GB
WisdomTree Foreign Excha...
USOTC
EVRRF
Molecule (PK)
BIT
UB3JUW
UniCredit Bank
USOTC
COLRD
China Medical and Health... (PK)
COIN
TRAAAUST
TRIA
NASDAQ
INDB
Independent Bank
NASDAQ
INVZ
Innoviz Technologies
COIN
SPECTBTC
Spectraal
BIT
P1TX77
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten